DK1449922T3 - Nukleinsyrefragmenter og polypeptidfragmenter afledt af M. tuberculosis - Google Patents
Nukleinsyrefragmenter og polypeptidfragmenter afledt af M. tuberculosisInfo
- Publication number
- DK1449922T3 DK1449922T3 DK04076605T DK04076605T DK1449922T3 DK 1449922 T3 DK1449922 T3 DK 1449922T3 DK 04076605 T DK04076605 T DK 04076605T DK 04076605 T DK04076605 T DK 04076605T DK 1449922 T3 DK1449922 T3 DK 1449922T3
- Authority
- DK
- Denmark
- Prior art keywords
- fragments
- tuberculosis
- nucleic acid
- polypeptides
- derived
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title abstract 3
- 229920001184 polypeptide Chemical group 0.000 title abstract 3
- 108090000765 processed proteins & peptides Chemical group 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 201000008827 tuberculosis Diseases 0.000 title abstract 2
- 150000007523 nucleic acids Chemical group 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 101710166488 6 kDa early secretory antigenic target Proteins 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK37697 | 1997-04-02 | ||
| US4462497P | 1997-04-18 | 1997-04-18 | |
| DK127797 | 1997-11-10 | ||
| US7048898P | 1998-01-05 | 1998-01-05 | |
| PCT/DK1998/000132 WO1998044119A1 (en) | 1997-04-02 | 1998-04-01 | NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1449922T3 true DK1449922T3 (da) | 2007-12-03 |
Family
ID=47018662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04076605T DK1449922T3 (da) | 1997-04-02 | 1998-04-01 | Nukleinsyrefragmenter og polypeptidfragmenter afledt af M. tuberculosis |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP1449922B1 (https=) |
| JP (4) | JP4172598B2 (https=) |
| AT (1) | ATE370236T1 (https=) |
| AU (1) | AU740545B2 (https=) |
| CA (1) | CA2285625C (https=) |
| DE (1) | DE69838268T2 (https=) |
| DK (1) | DK1449922T3 (https=) |
| ES (1) | ES2291810T3 (https=) |
| PT (1) | PT1449922E (https=) |
| WO (1) | WO1998044119A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6991797B2 (en) | 1993-07-02 | 2006-01-31 | Statens Serum Institut | M. tuberculosis antigens |
| US6982085B2 (en) | 1997-04-02 | 2006-01-03 | Statens Serum Institut | TB diagnostic based on antigens from M. tuberculosis |
| US7037510B2 (en) | 1997-04-18 | 2006-05-02 | Statens Serum Institut | Hybrids of M. tuberculosis antigens |
| CA2319380A1 (en) * | 1997-11-10 | 1999-05-20 | Statens Serum Institut | Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis |
| WO1999045119A2 (en) * | 1998-03-06 | 1999-09-10 | Statens Serum Institut | Production of mycobacterial polypeptides by lactic acid bacteria |
| AU2594500A (en) * | 1998-12-24 | 2000-07-31 | Corixa Corporation | Methods for using mycobacterium tuberculosis molecules as immunological adjuvants |
| EP2087906A1 (en) | 1999-05-04 | 2009-08-12 | The University of Medicine and Dentistry of New Jersey | Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| US6537552B1 (en) | 1999-10-19 | 2003-03-25 | Iowa State University Research Foundation | Vaccine adjuvant |
| AU2001250294A1 (en) * | 2000-04-19 | 2001-10-30 | Statens Serum Institut | Tuberculosis antigens and methods of use thereof |
| WO2002004018A2 (en) * | 2000-07-10 | 2002-01-17 | Colorado State University Research Foundation | Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| WO2004099771A1 (en) | 2003-05-08 | 2004-11-18 | Statens Serum Institut | A new specific epitope based immunological diagnosis of tuberculosis |
| CN102220357B (zh) | 2004-11-16 | 2013-12-25 | 克鲁塞尔荷兰公司 | 包含重组病毒载体的多价疫苗 |
| EP2441469A1 (en) * | 2006-03-14 | 2012-04-18 | Oregon Health and Science University | Methods for producing an immune response to tuberculosis |
| GB0618127D0 (en) * | 2006-09-14 | 2006-10-25 | Isis Innovation | Biomarker |
| US9297803B2 (en) | 2006-11-01 | 2016-03-29 | Immport Therapeutics, Inc. | Compositions and methods for immunodominant antigens |
| KR20140015127A (ko) * | 2009-07-29 | 2014-02-06 | 베른드 헬무트 아담 렘 | 폴리머 입자 및 이의 용도 |
| WO2011159814A2 (en) * | 2010-06-15 | 2011-12-22 | The Regents Of The University Of California | Novel live recombinant booster vaccine against tuberculosis |
| EP2838990A4 (en) * | 2012-04-16 | 2016-08-10 | Aeras Global Tb Vaccine Found | RECOMBINANT MYCOBACTERIUM FOR THE CODING OF A HEPARIN-BINDING HEMAGGLUTININE (HBHA) FUSION PROTEIN AND USES THEREOF |
| CN104897838B (zh) * | 2015-06-10 | 2016-08-17 | 重庆医科大学 | 一种强极性有机酸碱混合物的同时提取分离分析方法 |
| EP3966321A4 (en) * | 2019-05-07 | 2023-09-06 | Nanyang Technological University | Asx-specific protein ligases and uses thereof |
| CN113373162A (zh) * | 2020-03-09 | 2021-09-10 | 北京蛋白质组研究中心 | 结核分枝杆菌H37Rv新基因Rv0229A及其编码蛋白和应用 |
| BR112022021258A2 (pt) * | 2020-04-20 | 2023-01-17 | Univ Saskatchewan | Composições e métodos para prevenir, controlar e diagnosticar infecções micobacterianas |
| CN116082514B (zh) * | 2021-11-05 | 2024-02-13 | 安博智联(北京)生物科技有限公司 | 结核分枝杆菌特异性的重组融合蛋白em及其应用 |
| WO2025250534A1 (en) * | 2024-05-28 | 2025-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | T cell targets for tuberculosis vaccines |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK79893D0 (da) * | 1993-07-02 | 1993-07-02 | Statens Seruminstitut | New vaccine |
| NZ309945A (en) * | 1995-05-23 | 2001-04-27 | Univ California | Abundant extracellular products and their use as vaccines |
| AU727602B2 (en) * | 1995-09-01 | 2000-12-14 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| CA2230927A1 (en) * | 1995-09-01 | 1997-03-13 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
-
1998
- 1998-04-01 AT AT04076605T patent/ATE370236T1/de active
- 1998-04-01 PT PT04076605T patent/PT1449922E/pt unknown
- 1998-04-01 EP EP04076605A patent/EP1449922B1/en not_active Expired - Lifetime
- 1998-04-01 ES ES04076605T patent/ES2291810T3/es not_active Expired - Lifetime
- 1998-04-01 DK DK04076605T patent/DK1449922T3/da active
- 1998-04-01 EP EP98913536A patent/EP0972045A1/en not_active Withdrawn
- 1998-04-01 DE DE69838268T patent/DE69838268T2/de not_active Expired - Lifetime
- 1998-04-01 AU AU68204/98A patent/AU740545B2/en not_active Ceased
- 1998-04-01 WO PCT/DK1998/000132 patent/WO1998044119A1/en not_active Ceased
- 1998-04-01 CA CA2285625A patent/CA2285625C/en not_active Expired - Lifetime
- 1998-04-01 JP JP54107498A patent/JP4172598B2/ja not_active Expired - Lifetime
-
2007
- 2007-11-19 JP JP2007299636A patent/JP4406024B2/ja not_active Expired - Lifetime
-
2008
- 2008-05-19 JP JP2008131389A patent/JP4544434B2/ja not_active Expired - Lifetime
-
2010
- 2010-01-08 JP JP2010002535A patent/JP2010154856A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1449922A3 (en) | 2004-11-17 |
| JP2008301817A (ja) | 2008-12-18 |
| JP4172598B2 (ja) | 2008-10-29 |
| ATE370236T1 (de) | 2007-09-15 |
| DE69838268D1 (de) | 2007-09-27 |
| AU6820498A (en) | 1998-10-22 |
| JP4406024B2 (ja) | 2010-01-27 |
| JP4544434B2 (ja) | 2010-09-15 |
| EP0972045A1 (en) | 2000-01-19 |
| EP1449922B1 (en) | 2007-08-15 |
| CA2285625A1 (en) | 1998-10-08 |
| JP2010154856A (ja) | 2010-07-15 |
| WO1998044119A1 (en) | 1998-10-08 |
| EP1449922A2 (en) | 2004-08-25 |
| JP2008142079A (ja) | 2008-06-26 |
| DE69838268T2 (de) | 2008-05-08 |
| ES2291810T3 (es) | 2008-03-01 |
| PT1449922E (pt) | 2007-11-09 |
| JP2001515359A (ja) | 2001-09-18 |
| AU740545B2 (en) | 2001-11-08 |
| CA2285625C (en) | 2015-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1449922T3 (da) | Nukleinsyrefragmenter og polypeptidfragmenter afledt af M. tuberculosis | |
| ATE371727T1 (de) | Kdr, ein menschlicher tyrosin kinase rezeptor | |
| DK1218751T3 (da) | Cöliakidiagnose under anvendelse af et gliadinepitop | |
| WO2001079274A3 (en) | Tuberculosis antigens and methods of use thereof | |
| WO2001014539A3 (en) | Methods and compositions for the construction and use of fusion libraries | |
| PT85977A (en) | Process for the preparation of human apolipoprotein ai and their variant forms by recombinant dna methods | |
| NZ502391A (en) | Mammalian cytokine: interleukin-B30 and related reagents | |
| DK645887A (da) | Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse | |
| DK0975755T3 (da) | CRSP-protein (cysteinrige udskilte proteiner), nukleinsyremolekyler der koder herfor samt anvendelser deraf | |
| DK491487A (da) | Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme | |
| GB9722320D0 (en) | Human cell cycle checkpoint proteins | |
| SE9402089D0 (sv) | Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments | |
| ATE534742T1 (de) | Polypeptide und nukleinsäuren von phorphorymonas gingivalis | |
| DK1417222T3 (da) | Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop | |
| DE69840445D1 (de) | Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv | |
| ATE310810T1 (de) | Polypeptid und dafür kodierendes nukeinsäure | |
| ATE124420T1 (de) | Impfstoffe und testsätze für haemophilus influenzae. | |
| Marin et al. | Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus | |
| DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
| DK1241186T3 (da) | Humant vækststandsende specifikt gen-6 (gas-6) og nukleinsyrer kodende derfor | |
| WO1997008317A3 (en) | Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof | |
| DK128687D0 (da) | Proteiner samt deres fremstilling og anvendelse | |
| DE3876227D1 (de) | Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung. | |
| ATE492640T1 (de) | Loslösendes protein 5 - ucp5 | |
| BR0213029A (pt) | Receptor acoplado por proteìna g, gave10 |